Alexandria Real Estate Equities stock (US0152711022): shares gain ground after strong monthly run

Alexandria Real Estate Equities shares extended their recent advance on the NYSE, with the U.S. life science REIT now among the stronger performers in the real estate space after a double-digit monthly gain.

Alexandria Real Estate Equities shares continued to firm up in United States trading, with the NYSE-listed life science-focused REIT extending a roughly 23.9% stock-price gain over the past month that has put it among the better performers in the domestic real estate sector, according to a sector overview published on 05/29/2026.GuruFocus as of 05/29/2026 This move comes on the back of a first-quarter reporting season in the United States REIT universe where investors have been reassessing interest-rate expectations and demand for specialized office and laboratory space.

The stock most recently traded around the mid-USD 50 range on the New York Stock Exchange, after closing at USD 49.93 on 05/28/2026 before edging up to USD 50.06 on 05/29/2026, highlighting a modest daily advance layered on top of the strong month-long performance.StockInvest.us as of 05/29/2026 For U.S.-based investors tracking real estate benchmarks, the company remains part of the listed REIT universe that is sensitive to Federal Reserve policy and domestic capital-market conditions.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Alexandria Real Estate
• Sector/industry: Life science-focused office and laboratory REIT
• Headquarters/country: Pasadena, United States
• Core markets: Major U.S. innovation hubs including Boston, San Diego and the San Francisco Bay Area
• Key revenue drivers: Rental income and lease escalations from life science and technology campuses, plus development and redevelopment of laboratory and office properties
• Home exchange/listing venue: New York Stock Exchange (ARE)
• Trading currency: USD

Alexandria Real Estate Equities: core business model

Alexandria Real Estate Equities focuses on owning, developing and operating specialized life science and technology campuses in key U.S. innovation clusters, generating most of its revenue from long-term leases with biotechnology, pharmaceutical and research tenants.

Valuation metrics and multiples for Alexandria Real Estate Equities

Valuation for Alexandria Real Estate Equities is currently influenced by both its recent share-price appreciation and its underlying earnings profile as a U.S. REIT. In its latest reported quarter, the company posted funds-from-operations-like earnings of USD 1.73 per share for Q1, matching analyst expectations, while revenue declined by 11.5% year on year, according to a recent research summary.MarketBeat as of 05/29/2026 These figures frame the earnings base that feeds into common REIT valuation multiples such as price-to-FFO and net asset value premiums or discounts.

On the market side, a discounted cash-flow assessment published on 05/28/2026 estimated an intrinsic value of USD 79.27 per share for Alexandria Real Estate Equities, compared with a contemporaneous share price of USD 49.93, implying a roughly 37% discount to that modeled value at that time.Simply Wall St as of 05/28/2026 While such intrinsic-value estimates depend heavily on assumptions about growth, capitalization rates and interest rates, they illustrate how some valuation models currently compare the traded price of the NYSE-listed REIT to its projected cash flows.

Conclusion

Alexandria Real Estate Equities has delivered a notable share-price advance on the New York Stock Exchange over the past month, helped by improving sentiment toward specialized U.S. real estate and ongoing reassessment of rate expectations. Against this market backdrop, the latest quarterly earnings profile and discounted cash-flow work highlight how different valuation frameworks currently position the REIT relative to its traded price. For investors following U.S. listed equities, the stock remains closely tied to the health of life science leasing markets, development pipelines and broader real estate capital-market conditions.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.